A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bessel van der Kolk, MD
Trauma Research Foundation
Principal Investigator - Casey Paleos, MD
Affective Care
Principal Investigator - Cole Marta, MD
New School Research, LLC
Principal Investigator - Emma Hapke, MD
Dr. Simon Amar, Inc.
Principal Investigator - Josh Woolley, MD, PhD
University of California, San Francisco
Principal Investigator - Michael Bogenschutz, MD
New York University/Langone Medical Center/Bellevue Hospital
Principal Investigator - Randall Brown, MD, PhD
University of Wisconsin, Madison
Principal Investigator - Ray Worthy, MD
Ray Worthy Psychiatry, LLC
Principal Investigator - Revital Amiaz, MD
The Chaim Sheba Medical Center, Tel Hashomer Hospital
Principal Investigator - Scott Shannon, MD
Wholeness Center
Principal Investigator - Sylvestre Quevedo, MD
San Francisco Insight and Integration Center
Principal Investigator - Wael Garas, MD
Aguazul-Bluewater, Inc.
Principal Investigator - Yevgeniy Gelfand, MD
Zen Therapeutics Solutions, LLC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Health Center
Vancouver, British Columbia, Canada
- Dr. Simon Amar, Inc.
Montreal, Quebec, Canada
- Assaf Harofeh Research Fund
Be’er Ya‘aqov, Israel
- Sheba Fund for Health Services and Research
Tel Litwinsky, Israel
- New School Research Llt
North Hollywood, California, United States
- San Francisco Insight and Integration Center
San Francisco, California, United States
- University of California San Francisco
San Francisco, California, United States
- Aguazul-Blue Water Inc.
Boulder, Colorado, United States
- Wholeness Center
Fort Collins, Colorado, United States
- Ray Worthy Psychiatry Llc
New Orleans, Louisiana, United States
- Trauma Research Foundation
Boston, Massachusetts, United States
- New York Private Practice
New York, New York, United States
- New York University
New York, New York, United States
- Zen Therapeutic Solutions, Llc
Mt. Pleasant, South Carolina, United States
- University of Wisconsin at Madison
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Nov 2018
- Primary completion
- 11 Aug 2020
- Completion
- 21 Aug 2020
- Last update posted
- 6 Jun 2025
- Registered enrollment
- 100
- Registry id
- NCT03537014
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.